Health
Health Canada reviewing the use of drug Rosiglitazone on safety concerns
In light of recently published scientific studies and an upcoming U.S. Food and Drug Administration (FDA) Advisory Committee meeting examining the heart-related (cardiovascular) safety of the diabetes ……Read More
